Prediction of Recurrence and Survival for Triple-Negative Breast Cancer (TNBC) by a Protein Signature in Tissue Samples-Reference-Cited by-同舟云学术

Prediction of Recurrence and Survival for Triple-Negative Breast Cancer (TNBC) by a Protein Signature in Tissue Samples

Published:2015-11 Issue:11 Volume:14 Page:2936-2946
ISSN:1535-9476
Container-title:Molecular & Cellular Proteomics
language:en
Short-container-title:Molecular & Cellular Proteomics

Author:

Campone Mario,Valo Isabelle,Jézéquel Pascal,Moreau Marie,Boissard Alice,Campion Loic,Loussouarn Delphine,Verriele Véronique,Coqueret Olivier,Guette Catherine

Publisher

Elsevier BV

Subject

Molecular Biology,Biochemistry,Analytical Chemistry

Reference42 articles.

1. Triple-negative breast cancer;Foulkes;N. Engl. J. Med,2010

2. American Society of Clinical Oncology 2007 update of recommendations for the use of tumor markers in breast cancer;Harris;J. Clin. Oncol,2007

3. Shotgun proteomics of archival triple-negative breast cancer samples;Gámez-Pozo;Proteomics Clin. Appl,2013

4. Expression of metabolism-related proteins in triple-negative breast cancer;Kim;Int. J. Clin. Exp. Pathol,2014

5. Comparative proteomic profiling of triple-negative breast cancer reveals that up-regulation of RhoGDI-2 is associated to the inhibition of caspase 3 and caspase 9;Muñiz Lino;J. Proteomics,2014

Cited by 44 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Clinical Significance of Tryptophanyl-tRNA Synthetase 1 Gene Expression in Patients With Locally Advanced Gastric Cancer;Anticancer Research;2024-02

2. The Use of Schisandrin B to Combat Triple-Negative Breast Cancers by Inhibiting NLRP3-Induced Interleukin-1β Production;Biomolecules;2024-01-05

3. Omics Technologies Improving Breast Cancer Research and Diagnostics;International Journal of Molecular Sciences;2023-08-11

4. Advancements in Oncoproteomics Technologies: Treading toward Translation into Clinical Practice;Proteomes;2023-01-10

5. A Clinical Cognizance of Molecular and Pathological Diagnostic Approach of TNBC;Therapeutic Drug Targets and Phytomedicine For Triple Negative Breast Cancer;2023-01